Cross-amyloid interaction of Aβ and IAPP at lipid membranes.

[1]  A. Kapurniotu,et al.  Design of a mimic of nonamyloidogenic and bioactive human islet amyloid polypeptide (IAPP) as nanomolar affinity inhibitor of IAPP cytotoxic fibrillogenesis , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[2]  C. Aisenbrey,et al.  How is protein aggregation in amyloidogenic diseases modulated by biological membranes? , 2008, European Biophysics Journal.

[3]  Christian Leisner,et al.  Raft lipids as common components of human extracellular amyloid fibrils. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[4]  R. Seidel,et al.  Amyloidogenic propensities and conformational properties of ProIAPP and IAPP in the presence of lipid bilayer membranes. , 2009, Journal of molecular biology.

[5]  Sara M. Butterfield,et al.  Wechselwirkungen zwischen amyloidogenen Proteinen und Membranen: Modellsysteme liefern mechanistische Einblicke , 2010 .

[6]  S. Jayasinghe,et al.  Lipid membranes modulate the structure of islet amyloid polypeptide. , 2005, Biochemistry.

[7]  W. Banks,et al.  Permeability of the blood-brain barrier to amylin. , 1995, Life sciences.

[8]  K. Kjaer,et al.  Templating effect of lipid membranes on Alzheimer's amyloid beta peptide. , 2005, Chemphyschem : a European journal of chemical physics and physical chemistry.

[9]  M. Fändrich,et al.  Assembly of Alzheimer's Aβ peptide into nanostructured amyloid fibrils , 2011 .

[10]  Li‐Mei Yan,et al.  Ein IAPP‐Mimetikum blockiert die zytotoxische Aggregation von Aβ – die Kreuzunterdrückung der Amyloidtoxizität von Aβ und IAPP deutet auf einen molekularen Zusammenhang zwischen Alzheimer‐Krankheit und Typ‐II‐Diabetes hin , 2007 .

[11]  A. Kapurniotu,et al.  IAPP mimic blocks Abeta cytotoxic self-assembly: cross-suppression of amyloid toxicity of Abeta and IAPP suggests a molecular link between Alzheimer's disease and type II diabetes. , 2007, Angewandte Chemie.

[12]  Ronald Frank,et al.  Identification of hot regions of the Abeta-IAPP interaction interface as high-affinity binding sites in both cross- and self-association. , 2010, Angewandte Chemie.

[13]  R. Winter,et al.  Suppression of IAPP fibrillation at anionic lipid membranes via IAPP-derived amyloid inhibitors and insulin. , 2010, Biophysical chemistry.

[14]  N. Opitz,et al.  Temperature-pressure phase diagram of a heterogeneous anionic model biomembrane system: results from a combined calorimetry, spectroscopy and microscopy study. , 2011, Biochimica et biophysica acta.

[15]  A. Blume,et al.  Adsorption of Amyloid β (1–40) Peptide at Phospholipid Monolayers , 2005, Chembiochem : a European journal of chemical biology.

[16]  Ronald Wetzel,et al.  Seeding Specificity in Amyloid Growth Induced by Heterologous Fibrils* , 2004, Journal of Biological Chemistry.

[17]  Li‐Mei Yan,et al.  Hot‐Spot‐Regionen der Aβ‐IAPP‐Wechselwirkungsdomänen als hochaffine Bindungsstellen bei Kreuz‐ und Selbstassoziation , 2010 .

[18]  R. Turner,et al.  Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Maarten F. M. Engel.  Membrane permeabilization by Islet Amyloid Polypeptide. , 2009, Chemistry and physics of lipids.

[20]  T. Sanke,et al.  Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in Type 2 (non-insulin-dependent) diabetic patients , 1991, Diabetologia.

[21]  H. Lashuel,et al.  Amyloidogenic protein-membrane interactions: mechanistic insight from model systems. , 2010, Angewandte Chemie.

[22]  T. Hartmann,et al.  Amyloid beta-protein and lipid metabolism. , 2007, Biochimica et biophysica acta.

[23]  A. Meister,et al.  Mechanism of islet amyloid polypeptide fibrillation at lipid interfaces studied by infrared reflection absorption spectroscopy. , 2007, Biophysical journal.

[24]  Maarten F. M. Engel,et al.  Islet amyloid polypeptide inserts into phospholipid monolayers as monomer. , 2006, Journal of molecular biology.

[25]  Hans Förstl,et al.  Analysis of Heterogeneous βA4 Peptides in Human Cerebrospinal Fluid and Blood by a Newly Developed Sensitive Western Blot Assay* , 1996, The Journal of Biological Chemistry.

[26]  Norbert Opitz,et al.  Interaction of hIAPP with Model Raft Membranes and Pancreatic β‐Cells: Cytotoxicity of hIAPP Oligomers , 2010, Chembiochem : a European journal of chemical biology.

[27]  G. Gröbner,et al.  Misfolding of amyloidogenic proteins at membrane surfaces: the impact of macromolecular crowding. , 2007, Journal of the American Chemical Society.

[28]  M. Fändrich,et al.  DHPC strongly affects the structure and oligomerization propensity of Alzheimer's Aβ(1-40) peptide. , 2010, Journal of molecular biology.

[29]  M. Nicolls,et al.  The clinical and biological relationship between Type II diabetes mellitus and Alzheimer's disease. , 2004, Current Alzheimer research.

[30]  Roland Winter,et al.  Elucidating the mechanism of lipid membrane-induced IAPP fibrillogenesis and its inhibition by the red wine compound resveratrol: a synchrotron X-ray reflectivity study. , 2009, Journal of the American Chemical Society.